Suzhou Zelgen Biopharmaceuticals Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.000x

Suzhou Zelgen Biopharmaceuticals Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Suzhou Zelgen Biopharmaceuticals Co Ltd (688266) has a cash flow conversion efficiency ratio of 0.000x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥543.69K ≈ $79.56K USD) by net assets (CN¥1.15 Billion ≈ $168.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Suzhou Zelgen Biopharmaceuticals Co Ltd (2016–2024)

Cash flow conversion efficiency of Suzhou Zelgen Biopharmaceuticals Co Ltd from 2016 to 2024. This chart illustrates how Suzhou Zelgen Biopharmaceuticals Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Suzhou Zelgen Biopharmaceuticals Co Ltd (688266) share price today for real-time trading data and today's change.

Suzhou Zelgen Biopharmaceuticals Co Ltd Cash Flow Conversion Ratio Explained

Suzhou Zelgen Biopharmaceuticals Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Suzhou Zelgen Biopharmaceuticals Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Suzhou Zelgen Biopharmaceuticals Co Ltd ranked by their cash flow conversion efficiency. Also see 688266 company net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Pampa Energía S.A F:9PAA	-0.061x
Helmerich and Payne Inc NYSE:HP	0.014x
Nordic Semiconductor ASA OL:NOD	0.001x
HARBOUR ENE.SP.ADR LS-50 F:PQQ2	N/A
Korn Ferry NYSE:KFY	0.116x
Strauss Group TA:STRS	0.114x
Jiangsu Phoenix Publishing & Media Corp Ltd SHG:601928	0.031x
Shenzhen Yan Tian Port Holdings Co Ltd SHE:000088	0.008x

Annual Cash Flow Conversion Efficiency for Suzhou Zelgen Biopharmaceuticals Co Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of Suzhou Zelgen Biopharmaceuticals Co Ltd from 2016 to 2024. Review free cash flow generation of Suzhou Zelgen Biopharmaceuticals Co Ltd to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.25 Billion ≈ $183.29 Million	CN¥38.20 Million ≈ $5.59 Million	0.031x	+122.77%
2023-12-31	CN¥1.64 Billion ≈ $240.69 Million	CN¥-220.31 Million ≈ $-32.24 Million	-0.134x	+71.52%
2022-12-31	CN¥787.49 Million ≈ $115.23 Million	CN¥-370.34 Million ≈ $-54.19 Million	-0.470x	-29.62%
2021-12-31	CN¥1.25 Billion ≈ $183.37 Million	CN¥-454.62 Million ≈ $-66.53 Million	-0.363x	-78.48%
2020-12-31	CN¥1.69 Billion ≈ $247.53 Million	CN¥-343.86 Million ≈ $-50.32 Million	-0.203x	+91.69%
2019-12-31	CN¥73.75 Million ≈ $10.79 Million	CN¥-180.43 Million ≈ $-26.40 Million	-2.446x	-512.81%
2018-12-31	CN¥281.64 Million ≈ $41.21 Million	CN¥-112.44 Million ≈ $-16.45 Million	-0.399x	+73.07%
2017-12-31	CN¥73.02 Million ≈ $10.69 Million	CN¥-108.25 Million ≈ $-15.84 Million	-1.482x	-186.02%
2016-12-31	CN¥109.44 Million ≈ $16.01 Million	CN¥-56.72 Million ≈ $-8.30 Million	-0.518x	--

About Suzhou Zelgen Biopharmaceuticals Co Ltd

SHG:688266 China Biotechnology

Market Cap

$3.52 Billion

CN¥24.04 Billion CNY

Market Cap Rank

#4315 Global

#628 in China

Share Price

CN¥90.80

Change (1 day)

-0.49%

52-Week Range

CN¥75.75 - CN¥147.40

All Time High

CN¥147.40